Subscribe
maraze-shutterstock-com
MaraZe / Shutterstock.com
4 November 2015Big Pharma

WTO 'expected to announce' 17-year drug patent waiver for LDCs

The World Trade Organization (WTO) is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries (LDCs) from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
WTO fails to strike deal to waive COVID-19 IP
20 October 2020   Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.
Africa
WTO confirms 17-year extension to LDC patent waiver
6 November 2015   The World Trade Organization has granted permission for the world’s Least Developed Countries to be exempt from administering and enforcing patents directed to pharmaceutical drugs.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Biotechnology
WTO fails to strike deal to waive COVID-19 IP
20 October 2020   Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.
Africa
WTO confirms 17-year extension to LDC patent waiver
6 November 2015   The World Trade Organization has granted permission for the world’s Least Developed Countries to be exempt from administering and enforcing patents directed to pharmaceutical drugs.

More on this story

Biotechnology
WTO fails to strike deal to waive COVID-19 IP
20 October 2020   Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.
Africa
WTO confirms 17-year extension to LDC patent waiver
6 November 2015   The World Trade Organization has granted permission for the world’s Least Developed Countries to be exempt from administering and enforcing patents directed to pharmaceutical drugs.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB